amylyx glp-1 acquires Eiger's antagonist avexitide for $35.1m Amylyx pins its next hopes
Description
Using EHR data, Truveta Research explores prescribing patterns and patient characteristics for GLP-1 RA medications.
Very few include older adults at high risk
Gorilla Dash: the all-in-one franchise platform websites, CRM, email & SMS marketing, reputation, reporting and AI
It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration
Stopping semaglutide requires careful planning to minimize weight regain and metabolic disruption
Here's what you need to know before that deadline.
